FLNC and gastric cancer: Therefore, in this study, we investigated the promoter methylation in the serum DNA for FLNC, THBS1, UCHL1, and DLEC1 in 82 GC patients, 46 CAG subjects, and 40 healthy controls with clinicopathological factors to assess their value in diagnosis or prognosis for GC patients.